Evolution of Fluconazole Resistance Mechanisms and Clonal Types of

Fluconazole / pharmacology Candida parapsilosis / genetics Drug Resistance, Fungal / genetics Tertiary Care Centers Antifungal Agents / pharmacology Fungal Proteins / genetics Microbial Sensitivity Tests
Candida parapsilosis South Korea evolution fluconazole resistance microsatellite typing

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
15 11 2022
Historique:
pubmed: 14 10 2022
medline: 18 11 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

We investigated the evolution of fluconazole resistance mechanisms and clonal types of Candida parapsilosis isolates from a tertiary care hospital in South Korea. A total of 45 clinical isolates, including 42 collected between 2017 and 2021 and 3 collected between 2012 and 2013, were subjected to antifungal susceptibility testing, sequencing of fluconazole resistance genes (

Identifiants

DOI: 10.1128/aac.00889-22 PMID: 36226945 PMC: PMC9664844
pubmed: 36226945
doi: 10.1128/aac.00889-22
pmc: PMC9664844
doi:

Substances chimiques

Fluconazole 8VZV102JFY
Antifungal Agents 0
Fungal Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0088922

Références

Antimicrob Agents Chemother. 2021 Jan 20;65(2):
pubmed: 33257445
J Appl Microbiol. 2002;92(3):549-55
pubmed: 11872132
J Clin Microbiol. 2004 Oct;42(10):4468-72
pubmed: 15472295
BMC Infect Dis. 2015 Aug 18;15:340
pubmed: 26282840
J Clin Microbiol. 2002 Jul;40(7):2363-9
pubmed: 12089249
J Mycol Med. 2021 Jun;31(2):101110
pubmed: 33450538
Front Microbiol. 2018 Dec 05;9:2997
pubmed: 30568646
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32690638
Antimicrob Agents Chemother. 2015 Oct;59(10):6629-33
pubmed: 26248365
J Antimicrob Chemother. 2019 May 1;74(5):1260-1268
pubmed: 30753525
Mycoses. 2017 May;60(5):320-327
pubmed: 28101934
J Clin Microbiol. 2012 Nov;50(11):3435-42
pubmed: 22875889
Med Mycol. 2010 Jun;48(4):669-74
pubmed: 20392145
Microb Drug Resist. 2017 Dec;23(8):966-972
pubmed: 28353392
J Antimicrob Chemother. 2021 Jan 19;76(2):418-422
pubmed: 33175162
Front Cell Infect Microbiol. 2021 Apr 22;11:676177
pubmed: 33968809
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Bioinformatics. 2012 Oct 1;28(19):2537-9
pubmed: 22820204
Front Cell Infect Microbiol. 2020 May 21;10:206
pubmed: 32509592
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
Clin Infect Dis. 2009 Mar 1;48(5):503-35
pubmed: 19191635
Int J Antimicrob Agents. 2020 Jan;55(1):105799
pubmed: 31520783
PLoS One. 2013;8(3):e59373
pubmed: 23527176
Infect Drug Resist. 2017 Jul 31;10:237-245
pubmed: 28814889
J Clin Microbiol. 2003 Aug;41(8):3765-76
pubmed: 12904388
Antimicrob Agents Chemother. 2015 Feb;59(2):1030-7
pubmed: 25451046
J Clin Microbiol. 2005 Apr;43(4):1829-35
pubmed: 15815004
Mycoses. 2014 Oct;57(10):602-11
pubmed: 24863164
Front Cell Infect Microbiol. 2020 May 25;10:232
pubmed: 32523896
BMC Infect Dis. 2016 Aug 20;16(1):433
pubmed: 27544427
BMC Infect Dis. 2006 Feb 10;6:21
pubmed: 16472387
J Fungi (Basel). 2021 Mar 30;7(4):
pubmed: 33808442
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Antimicrob Agents Chemother. 2015 Oct;59(10):6581-7
pubmed: 26259795
Antimicrob Agents Chemother. 2015;59(6):3570-3
pubmed: 25779577
Med Mycol. 2007 Jun;45(4):321-46
pubmed: 17510856
Antibiotics (Basel). 2020 Jun 09;9(6):
pubmed: 32526921
J Clin Microbiol. 2017 Oct;55(10):2996-3005
pubmed: 28747370
Int J Microbiol. 2012;2012:713687
pubmed: 22187560
J Clin Microbiol. 2010 May;48(5):1677-82
pubmed: 20220157
Int J Antimicrob Agents. 2006 May;27(5):359-66
pubmed: 16647248
Antimicrob Agents Chemother. 2015 Oct;59(10):5942-50
pubmed: 26169412
Emerg Infect Dis. 2018 Sep;24(9):1768-1770
pubmed: 30124412
Antimicrob Agents Chemother. 2021 Feb 16;:
pubmed: 33593841
Mycoses. 2020 May;63(5):471-477
pubmed: 32124485

Auteurs

Tae Yeul Kim (TY)

Department of Laboratory Medicine and Genetics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.
ORCID: 0000-0002-6405-5305

Hee Jae Huh (HJ)

Department of Laboratory Medicine and Genetics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Ga Yeong Lee (GY)

Department of Laboratory Medicine, Chonnam National University School of Medicine, Gwangju, South Korea.

Min Ji Choi (MJ)

Department of Laboratory Medicine, Chonnam National University School of Medicine, Gwangju, South Korea.

Hui-Jin Yu (HJ)

Department of Laboratory Medicine and Genetics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Sun Young Cho (SY)

Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Yun Sil Chang (YS)

Department of Pediatrics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Yae-Jean Kim (YJ)

Department of Pediatrics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.

Jong Hee Shin (JH)

Department of Laboratory Medicine, Chonnam National University School of Medicine, Gwangju, South Korea.
ORCID: 0000-0001-9593-476X

Nam Yong Lee (NY)

Department of Laboratory Medicine and Genetics, Samsung Medical Centergrid.414964.a, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Articles similaires

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.

Victor Guan Hui Lee, Jerold Loh, Fu Hui et al.
1.00
Humans Female Alopecia Breast Neoplasms Middle Aged

Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents.

Doris Crnčević, Alma Ramić, Andreja Radman Kastelic et al.
1.00
Humans Microbial Sensitivity Tests Anti-Bacterial Agents Biofilms Quinuclidines

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Triazoles › Fluconazole › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Candida › Candida parapsilosis › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance des champignons aux médicaments › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Centres de soins tertiaires › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines fongiques › Evolution of Fluconazole Resistance Mechanisms...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Evolution of Fluconazole Resistance Mechanisms...